Chemoinformaics analysis of CICHORIC-ACID-METHYL-ESTER
| Molecular Weight | 448.38 | nRot | 9 |
| Heavy Atom Molecular Weight | 428.22 | nRig | 16 |
| Exact Molecular Weight | 448.101 | nRing | 2 |
| Solubility: LogS | -2.321 | nHRing | 0 |
| Solubility: LogP | 1.471 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 12 |
| nHA | 9 | APOL | 57.2279 |
| nHD | 6 | BPOL | 26.1401 |
| QED | 0.181 |
| Synth | 3.545 |
| Natural Product Likeliness | 1.294 |
| NR-PPAR-gamma | 0.647 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.032 |
| HIA | 0.36 |
| CACO-2 | -6.233 |
| MDCK | 0.0000304 |
| BBB | 0.07 |
| PPB | 0.973417 |
| VDSS | 0.315 |
| FU | 0.0311848 |
| CYP1A2-inh | 0.054 |
| CYP1A2-sub | 0.067 |
| CYP2c19-inh | 0.045 |
| CYP2c19-sub | 0.042 |
| CYP2c9-inh | 0.276 |
| CYP2c9-sub | 0.544 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.151 |
| CYP3a4-inh | 0.088 |
| CYP3a4-sub | 0.02 |
| CL | 3.785 |
| T12 | 0.967 |
| hERG | 0.007 |
| Ames | 0.019 |
| ROA | 0.059 |
| SkinSen | 0.597 |
| Carcinogencity | 0.068 |
| EI | 0.151 |
| Respiratory | 0.035 |
| NR-Aromatase | 0.05 |
| Antiviral | Yes |
| Prediction | 0.763233 |